Literature DB >> 11697329

Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.

S Masunaga1, K Ono, Y Sakurai, M Takagaki, T Kobayashi, Y Kinashi, M Suzuki.   

Abstract

PURPOSE: Response of quiescent (Q) and total tumor cells in solid tumors to reactor neutron beam irradiation with two different cadmium (Cd) ratios was examined in terms of micronucleus (MN) frequency and apoptosis frequency, using four different tumor cell lines. METHODS AND MATERIALS: C57BL mice bearing EL4 tumors, C3H/He mice bearing SCC VII or FM3A tumors, and Balb/c mice bearing EMT6/KU tumors received 5-bromo-2'-deoxyuridine (BrdU) continuously for 5 days via implanted mini-osmotic pumps to label all proliferating (P) cells. Thirty min after i.p. injection of sodium borocaptate-10B (BSH), or 3 h after oral administration of p-boronophenylalanine-10B (BPA), the tumors were irradiated with neutron beams. The tumors without 10B-compound administration were irradiated with neutron beams or gamma-rays. This neutron beam irradiation was performed using neutrons with two different Cd ratios. The tumors were then excised, minced, and trypsinized. The tumor cell suspensions thus obtained were incubated with cytochalasin-B (a cytokinesis blocker), and the MN frequency in cells without BrdU labeling (=Q cells) was determined using immunofluorescence staining for BrdU. Meanwhile, for apoptosis assay, 6 h after irradiation, tumor cell suspensions obtained in the same manner were fixed, and the apoptosis frequency in Q cells was also determined with immunofluorescence staining for BrdU. The MN and apoptosis frequencies in total (P + Q) tumor cells were determined from the tumors that were not pretreated with BrdU.
RESULTS: Without 10B-compounds, the sensitivity difference between total and Q cells was reduced by neutron beam irradiation. Under our particular neutron beam irradiation condition, relative biological effectiveness (RBE) of neutrons was larger in Q cells than in total cells, and the RBE values were larger for low Cd-ratio than high Cd-ratio neutrons. With 10B-compounds, both frequencies were increased for each cell population, especially for total cells. BPA increased both frequencies for total cells more than BSH did. Nevertheless, the sensitivity of Q cells treated with BPA was lower than that of Q cells treated with BSH. Whether based on the MN frequency or the apoptosis frequency, similar results concerning the sensitivity difference between total and Q cells, the values of RBE, and the enhancement effect by the use of 10B-compound were obtained.
CONCLUSION: Apoptosis frequency, as well as the MN frequency, can be applied to our method for measuring the Q cell response to reactor neutron beam irradiation within solid tumor in which the ratio of apoptosis to total cell death is relatively high, as in EL4 tumor. The absolute radiation dose required to achieve the same endpoint for Q cells is much higher than that for total cells when combined with 10B-compound, especially with BPA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697329     DOI: 10.1016/s0360-3016(01)01695-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.

Authors:  S Masunaga; Y Sakurai; H Tanaka; M Suzuki; Y Liu; N Kondo; A Maruhashi; Y Kinashi; K Ono
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

2.  Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Authors:  Shin-Ichiro Masunaga; Hideko Nagasawa; Keiko Gotoh; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
Journal:  Radiat Med       Date:  2006-02

3.  Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.

Authors:  Shin-Ichiro Masunaga; Koji Ono; Mitsunori Kirihata; Masao Takagaki; Yoshinori Sakurai; Yuko Kinashi; Tooru Kobayashi; Minoru Suzuki; Kenji Nagata; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Journal:  J Cancer Res Clin Oncol       Date:  2003-01-11       Impact factor: 4.553

4.  Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction.

Authors:  S Masunaga; Y Sakurai; H Tanaka; R Hirayama; Y Matsumoto; A Uzawa; M Suzuki; N Kondo; M Narabayashi; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

5.  Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.

Authors:  Peng Wang; Haining Zhen; Xinbiao Jiang; Wei Zhang; Xin Cheng; Geng Guo; Xinggang Mao; Xiang Zhang
Journal:  BMC Cancer       Date:  2010-12-02       Impact factor: 4.430

6.  The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Hiroki Tanaka; Keizo Tano; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Yosuke Nakagawa; Tsubasa Watanabe; Akira Maruhashi; Koji Ono
Journal:  Springerplus       Date:  2014-03-07

7.  Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Akira Maruhashi; Koji Ono
Journal:  J Radiat Res       Date:  2012-10-24       Impact factor: 2.724

8.  Apoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy.

Authors:  Fernanda Faião-Flores; Paulo Rogério Pinto Coelho; João Dias Toledo Arruda-Neto; Silvya Stuchi Maria-Engler; Manoela Tiago; Vera Luiza Capelozzi; Ricardo Rodrigues Giorgi; Durvanei Augusto Maria
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.

Authors:  Kiyoshi Takahara; Teruo Inamoto; Koichiro Minami; Yuki Yoshikawa; Tomoaki Takai; Naokazu Ibuki; Hajime Hirano; Hayahito Nomi; Shinji Kawabata; Satoshi Kiyama; Shin-Ichi Miyatake; Toshihiko Kuroiwa; Minoru Suzuki; Mitsunori Kirihata; Haruhito Azuma
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

10.  Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Keizo Tano; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Tsubasa Watanabe; Yosuke Nakagawa; Akira Maruhashi; Koji Ono
Journal:  Exp Ther Med       Date:  2014-05-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.